BABA
Alibaba Group Holding Limited
BABA has the edge over GIL overall, supported by stronger valuation and stronger modeled upside.
GIL
Gildan Activewear Inc.
GIL offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
GIL Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Healthy | |
| Weak |
GIL's revenue, profitability and cash flow are currently healthy, but its balance sheet is weak.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA has the edge over GIL in the historical PE scenario, which offers more potential upside but is not a forecast.
GIL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.3x | $34.83 | — |
| Cheap | 11x | $5.67 | -84% |
| Fair | 17x | $9.22 | -74% |
| Expensive | 24x | $12.73 | -63% |
| Current | 65x | $34.83 | — |
Historical ranges are pointers, not guarantees.
GIL's PE is in its expensive range at 65x. If earnings grow as analysts expect, today's price would be 8.3x next year's earnings, in its cheap range.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over GIL on the outlook, with more favorable revenue expectations.
GIL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect GIL's earnings to grow and its profitability to improve, with its revenue holding steady.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the stronger earnings trend. Trailing diluted EPS is down 52% for BABA versus GIL down 79%.
GIL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.21 | +680% |
| Q3 2025 | $3.13 | +24% |
| Q3 2024 | $2.52 | -3.8% |
| Q2 2024 | $2.43 | -11% |
| Q1 2024 | $2.96 | +10% |
| Q4 2023 | $3.04 | +4.1% |
| Q3 2023 | $2.62 | -22% |
| Q2 2023 | $2.73 | -21% |
| Q1 2023 | $2.69 | -20% |
GIL's earnings per share have fallen from their peak: $0.54 over the past year, against $3.45 in mid-2022.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA's revenue has grown year over year for 16 quarters in a row: $40.2B last quarter, up 8.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
GIL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.5B | +68% |
| Q1 2026 | $1.2B | +64% |
| Q4 2025 | $1.1B | +33% |
| Q3 2025 | $910.6M | +2.2% |
| Q2 2025 | $918.5M | +6.5% |
| Q1 2025 | $711.7M | +2.3% |
| Q4 2024 | $821.5M | +5% |
| Q3 2024 | $891.1M | +2.4% |
GIL has the edge over BABA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 17% | -4.9 points |
| Q1 2026 | 5.1% | -13 points |
| Q4 2025 | 17% | -4.6 points |
| Q3 2025 | 21% | N/A |
| Q2 2025 | 22% | +0.1 points |
| Q1 2025 | 18% | +2.2 points |
| Q4 2024 | 22% | +6.7 points |
| Q3 2024 | 22% | +3.8 points |
GIL has the edge over BABA on profitability, with a higher operating margin.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
GIL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $316.5M | +93% |
| Q1 2026 | -$309.9M | -$145.4M |
| Q4 2025 | $280.6M | +65% |
| Q3 2025 | $203.1M | +35% |
| Q2 2025 | $163.7M | +58% |
| Q1 2025 | -$164.5M | -$93.1M |
| Q4 2024 | $169.9M | -16% |
| Q3 2024 | $150.5M | -43% |
GIL has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has the edge over GIL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
GIL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +18K shares |
| 1 year | +23% | +34.4M shares |
| 3 years | +4.1% | +7.3M shares |
| 5 years | -7% | -13.9M shares |
| Available history | -8.9% | -18M shares |
GIL has 185M diluted shares, up 23% from a year ago, despite $109M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $4.8M |
| Q1 2026 | $71.5M |
| Q4 2025 | $3.4M |
| Q3 2025 | $29.4M |
| Q2 2025 | $77.1M |
| Q1 2025 | $87.4M |
| Q4 2024 | $220.6M |
| Q3 2024 | $381.2M |
GIL spent $109M buying back its own shares over the past year, down 86% from the year before.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA has the edge over GIL on leverage, with a lower net debt burden relative to earnings.
GIL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 6.4x | High |
| Q1 2026 | 7.5x | High |
| Q4 2025 | 6.1x | High |
| Q3 2025 | 2.2x | Moderate |
| Q3 2024 | 2.1x | Moderate |
| Q2 2024 | 1.8x | Healthy |
| Q1 2024 | 1.6x | Healthy |
| Q4 2023 | 1.4x | Healthy |
GIL's net debt is about 6.4 years of its operating earnings (EBITDA), up from 2.1 years a year ago.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
GIL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.2 | Oversold |
| Stochastic | 9.3 | Oversold |
GIL's weekly RSI is 26 (oversold) and its Stochastic is 9 (oversold).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA has the edge over GIL on valuation relative to its sector.
GIL PE vs Consumer Cyclical Sector
| Metric | GIL | Sector median | Relative |
|---|---|---|---|
| PE | 65x | 18x | 258% above |
| PE % | 96 | 47 | 49 pts above |
GIL is trading at 65x earnings, a 258% premium to the Consumer Cyclical sector's median of 18x.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
GIL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.3 | 11% below |
| 20 week MA | $47.5 | 27% below |
| 50 week MA | $55.7 | 37% below |
| 100 week MA | $53.4 | 35% below |
| 200 week MA | $44.5 | 22% below |
GIL is in a downtrend: it's below all five of its weekly moving averages, and 22% below its 200-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has the edge over GIL on returns for 2026, with the stronger performance.
GIL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.6 | $28.2 | -4.5% |
| 2021 | $28.2 | $40.8 | +44% |
| 2022 | $40.8 | $27.1 | -34% |
| 2023 | $27.1 | $33.1 | +22% |
| 2024 | $33.1 | $46.9 | +42% |
| 2025 | $46.9 | $63.6 | +36% |
| 2026 YTD | $63.6 | $34.8 | -45% |
GIL is down 45% so far in 2026, after finishing higher in four of the previous six years.